The death of a boy with Duchenne muscular dystrophy, tied to a gene therapy, is above all a tragedy. But it is also ...

New brain-computer interface reduced time lag in translating thoughts into speech in a meaningful advance for the field.

Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.

Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her ...

Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history ...

During a talk at the recent Jefferies Global Healthcare Conference, Cogent CEO Andy Robbins said Blueprint Medicines’ Ayvakit ...

Emotionally intelligent AI can generate trust, motivate action, elevate the relationship between patients and their care ...

Two advocates demand systemic change in addiction treatment that prioritizes safety and accountability above all else.

We look at the continued turmoil within the FDA, including the forced dismissal of top gene therapy regulator Nicole Verdun, as well as the announcement of a controversial drug-review voucher program ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

A U.K. health agency said the Alzheimer's drugs Kisunla and Leqembi are not cost-effective, meaning they won't be offered through the NHS.

Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...